News and Events
MetCure received a Phase I STTR grant from National Cancer Institute
This one-year Small Business Technology Transfer grant is to investigate the efficacy of a novel nutraceutical agent in enhancing standard prostate cancer therapy.
MetCure received a Phase IA Venture grant from Georgia Research Alliance
This grant is to support the research on a promising small-molecule cancer stem cell inhibitor in pre-clinical models of human prostate cancer.
Position Opening: Scientist I; MetCure Therapeutics LLC, Augusta, GA
Master’s degree with minimum 2 years relevant academic/industry experience or a combination of equivalent education and experience.
Degree in Cell Biology, Biotechnology, Biochemistry or related science.
Experience in animal models of human cancer (eg., xenograft models) is required
Experience in cell culture, molecular biology techniques (PCR, Western blotting, immunoprecipitation), immunohistochemistry is required
Excellent communication skills and ability to work effectively with multifunctional teams is required.
Ability to routinely work with spreadsheets, database programs, and statistical analysis software tools is required.
knowledge and experience in drug development is preferred.
Independently develop, execute and analyze experiments
Execute new product development and product support activities according to existing protocols or development or adaptation of new protocols as required
2 years experience Research Projects
2 years Cell culture
2 years Xenograft models of human cancer
2 years experience lab equipment
2 years experience statistical programs
- relevant academic/industry experience : 2 years